Israel’s Zebra Medical gets FDA ok for brain bleeds product
TEL AVIV (Reuters) – Zebra Medical Vision, an Israel medical imaging analytics company, said on Monday it received its third clearance from the U.S. Food and Drug Administration for its…
Take Five: The Fed and the rest
With President Donald Trump’s trade policies heightening fears of a U.S. recession, expectations of a Fed rate cut have dramatically increased in the past month. Money market pricing became even…
GE poised for significant power orders in Iraq after U.S. push -sources
NEW YORK/BAGHDAD/WASHINGTON (Reuters) – General Electric Co potentially stands to win a large share of multibillion-dollar contracts to rebuild Iraq’s electricity system, reflecting a change in how Iraq intends to…
U.S. cities propose framework for nationwide opioid settlement talks
(Reuters) – Lawyers for counties and municipalities suing drug manufacturers and distributors over their alleged roles in the U.S. opioid epidemic on Friday pitched a novel plan that would bring…
FDA approves Lilly’s migraine drug as first ever cluster headache treatment
NEW YORK (Reuters) – Eli Lilly and Co’s migraine treatment Emgality on Tuesday became the first drug to gain U.S. approval for decreasing the frequency of episodic cluster headache attacks,…
Israel heads to election as Netanyahu fails to form govt
Israel’s parliament voted to dissolve itself early Thursday, sending the country to an unprecedented second snap election this year as Prime Minister Benjamin Netanyahu failed to form a governing coalition…
U.S. football player’s overdose death spotlighted in J&J Oklahoma opioid trial
(Reuters) – The father of a college football player who died of a drug overdose gave emotional testimony about the U.S. opioid epidemic’s personal cost on Wednesday in the second…
J&J’s greed helped fuel U.S. opioid crisis, Oklahoma claims at trial
NORMAN, Okla. (Reuters) – Johnson & Johnson’s greed led the drugmaker to use deceptive marketing to create an oversupply of painkillers that fueled the U.S. opioid epidemic, the state of…
Teva Pharm to pay Oklahoma $85 million to settle opioid claims
BOSTON/JERUSALEM (Reuters) – Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set…
Oklahoma reaches $85 million settlement with Teva Pharmaceuticals ahead of trial
A man walks past the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017. REUTERS/Ammar Awad (Reuters) – Oklahoma has reached a $85 million settlement agreement…